---
schema_version: "secwatch.filing_event.v1"
accession: "0001534969-26-000024"
form_type: "8-K"
ticker: "SERA"
cik: "0001534969"
company_name: "SERA PROGNOSTICS, INC."
filed_at: "2026-05-06T23:59:59+00:00"
generated_at: "2026-05-14T22:37:41.087578+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sera Prognostics Q1 revenue minimal at $14K; PRIME trial shows 56% reduction in early preterm births

## Summary
- Q1 2026 revenue $14,000 vs $38,000 YoY; net loss $8.4M vs $8.2M; operating expenses $9.4M.
- PRIME trial (5,018 women) showed PreTRM test cut early preterm births 56% (<32 wks) and 32% (<35 wks); NICU admissions down 20%.
- Cash and securities $86.8M; cash runway extended through 2029 via cost restructuring.
- Launched third physician partnership; active payer discussions with 13 payers across 15 states.
- CE marking submission for Europe on track for mid-2026; expanding European evidence base.

## SEC filing metadata
- accession: 0001534969-26-000024
- form_type: 8-K
- ticker: SERA
- cik: 0001534969
- company_name: SERA PROGNOSTICS, INC.
- filed_at: 2026-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534969/000153496926000024/0001534969-26-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534969/000153496926000024/sera-20260506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001534969-26-000024
- JSON: https://secwatch.observer/filing/0001534969-26-000024.json
- Plain text: https://secwatch.observer/filing/0001534969-26-000024.txt

## Source-grounded claims
- claim_id: 5c5b81b2e9e3e5d35158e73804eba1c52a7dc904
  claim: SERA PROGNOSTICS, INC. reported the first quarter ended March 31, 2026 results: revenue $14,000, net income $8.4 million.
  evidence_excerpt: First quarter 2026 revenue was $14,000 compared to $38,000 for the first quarter of 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534969/000153496926000024/0001534969-26-000024-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.